<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-GO2QDXME</identifier><date>2013</date><creator>Antolič, Rok</creator><relation>documents/doc/G/URN_NBN_SI_doc-GO2QDXME_001.htm</relation><relation>documents/doc/G/URN_NBN_SI_doc-GO2QDXME_001.pdf</relation><relation>documents/doc/G/URN_NBN_SI_doc-GO2QDXME_001.txt</relation><format format_type="issue">4</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 304-308</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">27312935</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-GO2QDXME</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">bolniki</subject><subject language_type_id="slv">farmakoterapija</subject><subject language_type_id="slv">zavzetost za zdravljenje z zdravili</subject><title>Medication interest - why is it so low and what can we do about it?</title><title>Zavzetost za zdravljenje z zdravili - zakaj je tako nizka in kaj lahko storimo?</title></Record>